F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump


The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease. (Ny Times Science) More More

Similar stories

COVID-19 tracker: Azar pegs 6.4M Pfizer doses for mid-December delivery; GAVI welcomes AZ shot data - FiercePharma

COVID-19 tracker: Azar pegs 6.4M Pfizer doses for mid-December delivery; GAVI welcomes AZ shot data  FiercePharma

Posted on 25 November 2020 | 9:30 am | Google News

Coronavirus Roundup: FDA Approves Second Antibody Treatment; HHS Seeks Feedback on Handling of the Pandemic - GovExec.com

Coronavirus Roundup: FDA Approves Second Antibody Treatment; HHS Seeks Feedback on Handling of the Pandemic  GovExec.com

Posted on 23 November 2020 | 12:17 pm | Google News

FDA grants EUA to Regeneron's antibody treatment for COVID-19 - BioWorld Online

FDA grants EUA to Regeneron's antibody treatment for COVID-19  BioWorld Online

Posted on 23 November 2020 | 12:00 pm | Google News

What We're Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage - AJMC.com Managed Markets Network

What We're Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage  AJMC.com Managed Markets Network

Posted on 23 November 2020 | 10:35 am | Google News

FDA approves Regeneron's Covid-19 antibody treatment - msnNOW

FDA approves Regeneron's Covid-19 antibody treatment  msnNOW

Posted on 22 November 2020 | 6:44 pm | Google News

Health Canada grants emergency-use authorization to Eli Lilly's COVID-19 antibody treatment - CTV News

Health Canada grants emergency-use authorization to Eli Lilly's COVID-19 antibody treatment  CTV News

Posted on 22 November 2020 | 3:40 pm | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info